Latest News about ALLK
Recent news which mentions ALLK
12 biotech stocks to consider buying now as prospects for the sector brighten this year
February 06, 2022
From MarketWatch
5 Important Investing Lessons From Allakos’ Price Collapse
January 24, 2022
Tickers
ALLK
From InvestorPlace
Allakos Is a Cautionary Tale of Biopharmaceutical Investing
January 12, 2022
Tickers
ALLK
From InvestorPlace
Why Allakos Stock Plummeted 87.5% in the Last Month of 2021
January 06, 2022
Tickers
ALLK
From Motley Fool
After a Clinical-Data Bombshell, Allakos Might Actually Be a Buy
January 05, 2022
Tickers
ALLK
From InvestorPlace
54 Biggest Movers From Thursday
December 27, 2021
From Benzinga
The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year
December 26, 2021
From Benzinga
Mid-Afternoon Market Update: Dow Surges 275 Points; SciPlay Shares Slide
December 23, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
December 23, 2021
From Benzinga
Mid-Day Market Update: Nasdaq Rises 100 Points; Quidel Shares Plummet
December 23, 2021
From Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
December 23, 2021
From Benzinga
10 Biggest Price Target Changes For Thursday
December 23, 2021
From Benzinga
From InvestorPlace
18 Stocks Moving in Thursday's Pre-Market Session
December 23, 2021
From Benzinga
50 Biggest Movers From Yesterday
December 23, 2021
From Benzinga
Mid-Afternoon Market Update: CalAmp Drops After Q3 Results; Red Cat Holdings Shares Surge
December 22, 2021
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 22, 2021
From Benzinga
ALLK Stock Alert: Why Is Allakos Absolutely Plunging Today?
December 22, 2021
Tickers
ALLK
From InvestorPlace
From Benzinga
32 Stocks Moving In Wednesday's Mid-Day Session
December 22, 2021
From Benzinga
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 22, 2021
December 22, 2021
From Benzinga
From Motley Fool
Allakos' Shares Nosedive After Lirentelimab Studies Fail To Achieve Statistical Significance On Symptomatic Endpoints
December 22, 2021
Tickers
ALLK
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.